• About
  • Advertise
  • Privacy & Policy
  • Contact
HK Businesswire
  • Home
  • News
    • All
    • Business
    • Politics
    • PR Newswire
    • Science
    • World

    EC election ‘open, honest and fair’, says David Lok

    Chongqing International Talent Exchange Conference Opens, Drawing Nobel Laureates and Global Innovators

    Chongqing International Talent Exchange Conference Opens, Drawing Nobel Laureates and Global Innovators

    APEC Business Travel Card is Linking Zhongshan with Asia-Pacific

    APEC Business Travel Card is Linking Zhongshan with Asia-Pacific

    Fossil fuels still missing from latest COP31 draft

    HK-Chile working-holiday scheme to start next year

    HK to contribute to global bay area cooperation: FS

    Trending Tags

    • Trump Inauguration
    • United Stated
    • White House
    • Market Stories
    • Election Results
  • PR Newswire
  • Business
  • World
  • Entertainment
  • Sports
  • Tech
    • All
    • Apps
    • Gadget
    • Mobile
    • Startup

    Cathay Cargo Launches AI Compliance Tool to Streamline Global Trade Operations

    PCCW Global and Druid Technology Partner on Belt and Road IoT Connectivity

    Alipay Launches Domestic Full-Stack Intelligent Agent Platform in Hangzhou

    HKT Posts 4% Profit Rise Amid Steady Local Recovery and AI-Driven Demand

    Alipay Launches AI-Powered Version ‘Abao’ to Streamline Services

    Xiaohongshu Prepares Confidential Hong Kong IPO Filing

    Trending Tags

    • Nintendo Switch
    • CES 2017
    • Playstation 4 Pro
    • Mark Zuckerberg
  • Feature
No Result
View All Result
  • Home
  • News
    • All
    • Business
    • Politics
    • PR Newswire
    • Science
    • World

    EC election ‘open, honest and fair’, says David Lok

    Chongqing International Talent Exchange Conference Opens, Drawing Nobel Laureates and Global Innovators

    Chongqing International Talent Exchange Conference Opens, Drawing Nobel Laureates and Global Innovators

    APEC Business Travel Card is Linking Zhongshan with Asia-Pacific

    APEC Business Travel Card is Linking Zhongshan with Asia-Pacific

    Fossil fuels still missing from latest COP31 draft

    HK-Chile working-holiday scheme to start next year

    HK to contribute to global bay area cooperation: FS

    Trending Tags

    • Trump Inauguration
    • United Stated
    • White House
    • Market Stories
    • Election Results
  • PR Newswire
  • Business
  • World
  • Entertainment
  • Sports
  • Tech
    • All
    • Apps
    • Gadget
    • Mobile
    • Startup

    Cathay Cargo Launches AI Compliance Tool to Streamline Global Trade Operations

    PCCW Global and Druid Technology Partner on Belt and Road IoT Connectivity

    Alipay Launches Domestic Full-Stack Intelligent Agent Platform in Hangzhou

    HKT Posts 4% Profit Rise Amid Steady Local Recovery and AI-Driven Demand

    Alipay Launches AI-Powered Version ‘Abao’ to Streamline Services

    Xiaohongshu Prepares Confidential Hong Kong IPO Filing

    Trending Tags

    • Nintendo Switch
    • CES 2017
    • Playstation 4 Pro
    • Mark Zuckerberg
  • Feature
No Result
View All Result
HK Businesswire
No Result
View All Result
Home News PR Newswire

PharmaResearch Global Symposium Draws More Than 750 Clinicians From 64 Countries

PR Newswire by PR Newswire
18 November 2026
in PR Newswire
0
PharmaResearch Global Symposium Draws More Than 750 Clinicians From 64 Countries
0
SHARES
2
VIEWS
Share on FacebookShare on Twitter

The seventh symposium in Gangneung, South Korea, featured clinical research on REJURAN® polynucleotides and a behind-the-scenes look at how the products are made

GANGNEUNG, South Korea, Nov. 18, 2026 /PRNewswire/ — PharmaResearch, the Korean pharmaceutical company behind the globally recognized skin booster REJURAN, brought together more than 750 medical professionals from 64 countries for its seventh PharmaResearch Global Symposium (PGS), held Oct. 26–28 in Gangneung, South Korea. The event gave clinicians working in aesthetic and regenerative medicine a chance to compare their experiences with polynucleotides (PN) and polydeoxyribonucleotides (PDRN) and discuss emerging approaches to treatment.

The seventh PharmaResearch Global Symposium at the Gangneung Convention Center in Gangneung, South Korea.  (Photo courtesy of PharmaResearch)
The seventh PharmaResearch Global Symposium at the Gangneung Convention Center in Gangneung, South Korea. (Photo courtesy of PharmaResearch)

The program began with a look at how PharmaResearch sources and processes the raw material behind its PN and PDRN products. At a Korea Fisheries Resources Agency center, attendees saw how raw material is obtained from wild salmon and prepared for manufacturing. The tour continued at PharmaResearch’s Gangneung plant, where they followed the material through processing, production and quality control.

The scientific program turned to how REJURAN PN, developed using PharmaResearch’s proprietary DNA Optimizing Technology (DOT®), is being studied and used in clinical practice. Across four sessions, clinicians discussed the evidence behind REJURAN, approaches to treatment and ways to improve the patient experience.

Safety was one focus of the discussion. U.S. physician Dr. Suneel Chilukuri reviewed the safety profile of REJURAN PN, and Drs. Atchima Suwanchinda and Thanya Techapichetvanich from Thailand shared recent research on PN across several treatment areas. The program also examined what may be happening at the tissue level, with Australian physician Dr. Steven Liew discussing what histological findings suggest about how PN may support skin repair.

Clinical cases brought those discussions into the treatment room. Dr. Yuri Yogya shared cases from his practice in Indonesia involving the lip area, while Japan’s Dr. Soichiro Morikawa discussed his experience combining PN with other treatments.

South Korean actress Kim Sejeong, a global ambassador for REJURAN and REJURAN COSMETICS, also attended the symposium.

“It was an honor to be part of an event that brought together so many clinicians and researchers from around the world,” Kim said. “I hope to bring REJURAN’s message about caring for your natural beauty and feeling confident in yourself to more people around the world.”

“The symposium gave clinicians from around the world a chance to review the clinical evidence and safety data for DOT® PN and discuss how that research could inform future treatment protocols,” a PharmaResearch spokesperson said. “We’ll continue to expand these exchanges in South Korea and internationally to help advance clinical practice in medical aesthetics.”

About PharmaResearch

PharmaResearch is a pioneering South Korean biopharmaceutical company dedicated to enhancing quality of life through regenerative medicine. Its portfolio spans medicines, medical devices, cosmetics and health supplements, built around its core DOT® PDRN and DOT® PN technologies, which are protected by multiple patents. PharmaResearch is headquartered in Gangneung, South Korea.

The company is behind REJURAN, its globally recognized PN-based skin booster available in more than 50 countries, and REJURAN COSMETICS, its premium derma-cosmetic brand.

Tags: prnewswire
PR Newswire

PR Newswire

PR Newswire is the industry’s leading press release distribution partner with an unparalleled global reach of more than 440,000 newsrooms, websites, direct feeds, journalists and influencers and is available in more than 170 countries and 40 languages. From our award-winning Content Services offerings, integrated media newsroom and microsite products, Investor Relations suite of services, paid placement and social sharing tools, PR Newswire has a comprehensive catalog of solutions to solve the modern-day challenges PR and communications teams face. For 70 years, PR Newswire has been the preferred destination for brands to share their most important news stories across the world.

Read More

CARsgen Presents First Clinical Data on Its In Vivo CAR-T Product Candidate CT1182

CARsgen Presents First Clinical Data on Its In Vivo CAR-T Product Candidate CT1182

22 November 2026
DataBeyond Showcases AI Sorting Solutions for Circular Supply Chains at COP31

DataBeyond Showcases AI Sorting Solutions for Circular Supply Chains at COP31

22 November 2026
  • Trending
  • Comments
  • Latest
Newgen reports Revenue of ₹357 crores in Q1 FY’27, up 11% Q1 YoY; Profit After Tax at ₹63 crores, up 26% Q1 YoY

Newgen Software and the Asian Institute of Digital Finance Forge Strategic Partnership to Shape the Future of Enterprise AI

10 November 2026

World Winter Sports Expo 2026 Opens, Charting a New Decade for Ice and Snow and Outdoor Industries

17 October 2026

HK five-year plan offers UK long-term prospects: CE

10 November 2026
Patriot Launches AI Matrix SSD and DRAM Series Engineered for Local AI Workloads

Patriot Launches AI Matrix SSD and DRAM Series Engineered for Local AI Workloads

19 November 2026

EC election ‘open, honest and fair’, says David Lok

22 November 2026
Chongqing International Talent Exchange Conference Opens, Drawing Nobel Laureates and Global Innovators

Chongqing International Talent Exchange Conference Opens, Drawing Nobel Laureates and Global Innovators

22 November 2026
APEC Business Travel Card is Linking Zhongshan with Asia-Pacific

APEC Business Travel Card is Linking Zhongshan with Asia-Pacific

22 November 2026

Fossil fuels still missing from latest COP31 draft

22 November 2026

Recent News

EC election ‘open, honest and fair’, says David Lok

22 November 2026
Chongqing International Talent Exchange Conference Opens, Drawing Nobel Laureates and Global Innovators

Chongqing International Talent Exchange Conference Opens, Drawing Nobel Laureates and Global Innovators

22 November 2026
APEC Business Travel Card is Linking Zhongshan with Asia-Pacific

APEC Business Travel Card is Linking Zhongshan with Asia-Pacific

22 November 2026

Fossil fuels still missing from latest COP31 draft

22 November 2026
HK Businesswire

Stay ahead with the latest insights on Hong Kong’s economy, finance, and investments. From market trends to policy updates, we bring you in-depth analysis and expert opinions.

📩 Subscribe to our newsletter for exclusive updates.
📍 Follow us on social media for real-time news.
📧 Contact us: info@hongkong-invest.com

Follow Us

  • About
  • Advertise
  • Privacy & Policy
  • Contact

© 2025 by HKBusinesswire.com

No Result
View All Result

© 2025 by HKBusinesswire.com